Hotchkis & Wiley Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,647,243	Closed	-$3.95M	–	500
2023 Q4	$3.95M	Sell	1,647,243 -781,247	-32%	-$1.84M	0.01%	408
2023 Q3	$8.26M	Buy	2,428,490 +1,294,070	+114%	+$7.17M	0.03%	245
2023 Q2	$8.34M	Buy	1,134,420 +190,760	+20%	+$1.77M	0.03%	236
2023 Q1	$9.78M	Buy	943,660 +106,300	+13%	+$1.28M	0.04%	177
2022 Q4	$9.89M	Buy	837,360 +484,860	+138%	+$7.5M	0.04%	158
2022 Q3	$7.4M	Buy	352,500 +80,440	+30%	+$2.24M	0.03%	206
2022 Q2	$8.45M	Buy	272,060 +28,800	+12%	+$983K	0.03%	200
2022 Q1	$9.99M	Buy	243,260 +13,030	+6%	+$575K	0.03%	182
2021 Q4	$10M	Buy	230,230 +79,000	+52%	+$3.57M	0.03%	152
2021 Q3	$7.57M	Buy	+151,230	New	+$9.16M	0.02%	223
2019 Q1	–	Sell	-35,794	Closed	-$2.12M	–	491
2018 Q4	$2.12M	Sell	35,794 -11,754	-25%	-$758K	0.01%	314
2018 Q3	$3.13M	Buy	47,548 +12,356	+35%	+$721K	0.01%	308
2018 Q2	$1.78M	Buy	35,192 +15,685	+80%	+$817K	0.01%	344
2018 Q1	$1.03M	Hold	19,507	–	–	﹤0.01%	317
2017 Q4	$906K	Buy	+19,507	New	+$821K	﹤0.01%	324